Pseudoexfoliation and Chronic Kidney Disease
The Relationship Between Pseudoexfoliation and Chronic Kidney Disease
1 other identifier
observational
358
1 country
1
Brief Summary
Background: Pseudoexfoliation (PEX) is characterised by the deposition of fibrillar material in an eye structures and many other parts of the body including kidneys and blood vessels. As both PEX and chronic kidney disease (CKD) are associated with oxidative stress and endothelial dysfunction we studied if the risk of PEX was increased in patients with CKD. Methods: Patients over age 40 with the diagnosis of CKD were included in the study. Chronic kidney disease was diagnosed as decreased glomerular filtration rate (GFR) of less than 60 mL/min/1.73 m². Study groups were arranged as group 1 consisting of HD receiving patients, group 2 consisting of stage 1-4 CKD patients and group 3 consisting of patients with normal kidney functions (control group). Demographic properties and the rate of PEX were evaluated and compaired between the groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 20, 2012
CompletedFirst Posted
Study publicly available on registry
September 26, 2012
CompletedSeptember 26, 2012
September 1, 2012
September 20, 2012
September 24, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalance of pseudoexfoliation in patients with chronic kidney disease
7 months
Study Arms (3)
Dialysis patients
Patients with stage 5 chronic kidney disease undergoing haemodialysis
Chronic kidney disease patients
Stage 1-4 Chronic kidney disease patients
Control group
Patients with normal renal functions
Eligibility Criteria
Patients from nephrology clinic
You may qualify if:
- All patients with chronic kidney disease stage 1-5
You may not qualify if:
- History of eye trauma or surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Corum State Hospital
Çorum, 19000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Leyla Niyaz, M.D.
Specialist in Ophthalmology
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ophthalmology Specialist
Study Record Dates
First Submitted
September 20, 2012
First Posted
September 26, 2012
Study Start
October 1, 2011
Study Completion
April 1, 2012
Last Updated
September 26, 2012
Record last verified: 2012-09